CHRISTIE DIPIETRANTONIO: Open Payments
NPI 1356116362 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,477 in 30 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,477
Food & beverage: $1,377Education: $100
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 2 | $333 |
| Lilly USA, LLC | 7 | $232 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $191 |
| Janssen Biotech, Inc. | 7 | $190 |
| Incyte Corporation | 3 | $179 |
| Botanix SB Inc | 1 | $127 |
| Novartis Pharmaceuticals Corporation | 1 | $116 |
| BioWound Solutions, Inc. | 1 | $48 |
| Cipher Pharmaceuticals US LLC | 1 | $40 |
| UCB, Inc. | 1 | $22 |
Products named: TREMFYA, NEMLUVIO, SOFDRA, EBGLYSS, Rhapsido, TALTZ, ILUMYA, bio-ConneKt.
Industry payments across NY — which companies pay providers there.
